Researchers hope that commercially available inhalers could be used to deliver novel treatment to infected lungs.
Corbevax vaccine offers solution to global vaccine inequity
The Corbevax COVID-19 vaccine was developed by researchers in Texas with no patent, and could be the end of global vaccine inequity.
Innovative science in 2021
Catch up on some of the most exciting and impactful developments in science from this year, published on ASN and selected by our editors.
Computer simulations pave the way for improved mRNA vaccines
Molecular dynamics offer ways to improve lipid-based therapeutic delivery systems.
Researchers develop Raman barcodes to keep track of SARS-CoV-2 variants
A fast and efficient means of record keeping could improve the ability to trace structural differences in viral variants.
Omicron reduces vaccine efficacy, but boosters improve protection
Preliminary data indicates that booster shots improve antibody levels 25-fold compared to just two doses.
Antibodies active against SARS-CoV-2 found in 20-year-old library
Three potent antibodies against SARS-CoV-2 identified in healthy individuals decades ago raises interesting questions about their origins and evolution.
Real progress made this year in the fight against malaria
Antibody therapies and new vaccines have been added to the arsenal, giving hope to the millions who live where malaria is endemic.
New Pfizer and Merck antivirals look hopeful
With SARS-CoV-2 continuing to circulate, new oral antivirals promise to be game changers in helping to end the pandemic.
Common concerns of the clean energy transition
With questions centered around cost and how long the transition will take, how do we convince people that the transition to renewables will be worth it?










